Financials

  • Market Capitalization 11.36 B
  • Employee 3 000
  • Founded 1976
  • CEO Charles R. Kummeth
  • Website www.bio-techne.com
  • Headquarter Minnesota, United States
  • FIGI BBG000C15114
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
60.91
Price to sales ratio
9.13
Dividends per share
0.32
Dividend yield %
0.45

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
824
HALO
Halozyme Therapeutics, Inc. - Common Stock
106.92 USD-0.13%+0.68%+28.70%+60.06%12.14 B USD
852
SMMT
Summit Therapeutics Inc. - Common Stock
14.33 USD+0.70%+12.83%+13.64%-27.84%11.43 B USD
875
CYTK
Cytokinetics, Incorporated - Common Stock
77.90 USD-1.64%+0.78%-2.34%+34.08%10.83 B USD
880
AXSM
Axsome Therapeutics, Inc. - Common Stock
206.27 USD-0.42%-0.46%-12.56%+58.43%10.80 B USD

Frequently asked questions about Bio-Techne Corp.

What is the Bio-Techne Corp. stock price today?

The current price of Bio-Techne Corp. (TECH) is 72.47. Over the past 24 hours, the stock has changed by +0.12%. Follow the TECH chart for real-time price dynamics.

What is the stock ticker of Bio-Techne Corp.?

Bio-Techne Corp. trades under the ticker TECH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bio-Techne Corp. stock going up?

TECH has changed by +0.19% over the last week, +0.47% over the last month, and +33.83% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Bio-Techne Corp.?

Bio-Techne Corp. currently has a market capitalization of 11.36 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Bio-Techne Corp. release financial reports?

Yes. You can track Bio-Techne Corp. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Bio-Techne Corp. earnings last quarter?

Last quarter, Bio-Techne Corp. reported earnings of 0.35 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Bio-Techne Corp. revenue for the last quarter?

Bio-Techne Corp. reported quarterly revenue of 321.19 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Bio-Techne Corp. net income for the last quarter?

Bio-Techne Corp. reported net income of 54.62 M for the last quarter. The previous quarter showed 51.05 M, which means net income changed by +7.00%.

Does Bio-Techne Corp. pay dividends?

Bio-Techne Corp. paid a dividend per share of 0.32. The current dividend yield is 0.45%. Dividend data can help income-focused investors evaluate the stock.

Is Bio-Techne Corp. a good dividend stock?

Bio-Techne Corp. currently has a dividend yield of 0.45%. Previously, the dividend yield was 1.07%, compared with 0.95% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.

How many employees does Bio-Techne Corp. have?

As of the latest available data, Bio-Techne Corp. has 3 000 employees. Workforce size can provide additional context about the company's scale and operations.

What is Bio-Techne Corp. EBITDA?

Bio-Techne Corp. EBITDA is 98.42 M, and its EBITDA margin is 30.64%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Bio-Techne Corp. stock?

You can buy Bio-Techne Corp. (TECH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bio-Techne Corp. stock?

Investing in Bio-Techne Corp. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TECH chart and related analysis on metatrader.com as part of your research.

Bio-Techne Corp - Common Stock

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

News